A carregar...
Treatment With Tafamidis Slows Disease Progression in Early-Stage Transthyretin Cardiomyopathy
BACKGROUND: Transthyretin cardiomyopathy (TTR-CM) is a progressive, fatal disease caused by the accumulation of misfolded transthyretin (TTR) amyloid fibrils in the heart. Tafamidis is a kinetic stabilizer of TTR that inhibits misfolding and amyloid formation. METHODS: In this post hoc analysis, dat...
Na minha lista:
| Publicado no: | Clin Med Insights Cardiol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5606341/ https://ncbi.nlm.nih.gov/pubmed/28951660 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1179546817730322 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|